GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (HKSE:01696) » Definitions » EV-to-EBIT

Sisram Medical (HKSE:01696) EV-to-EBIT : 5.50 (As of May. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sisram Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sisram Medical's Enterprise Value is HK$1,685 Mil. Sisram Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$307 Mil. Therefore, Sisram Medical's EV-to-EBIT for today is 5.50.

The historical rank and industry rank for Sisram Medical's EV-to-EBIT or its related term are showing as below:

HKSE:01696' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.09   Med: 6.77   Max: 89.81
Current: 5.42

During the past 10 years, the highest EV-to-EBIT of Sisram Medical was 89.81. The lowest was 1.09. And the median was 6.77.

HKSE:01696's EV-to-EBIT is ranked better than
87.96% of 457 companies
in the Medical Devices & Instruments industry
Industry Median: 20.37 vs HKSE:01696: 5.42

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sisram Medical's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,395 Mil. Sisram Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$307 Mil. Sisram Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 12.80%.


Sisram Medical EV-to-EBIT Historical Data

The historical data trend for Sisram Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical EV-to-EBIT Chart

Sisram Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.41 6.08 10.47 10.80 7.83

Sisram Medical Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.47 - 10.80 - 7.83

Competitive Comparison of Sisram Medical's EV-to-EBIT

For the Medical Devices subindustry, Sisram Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sisram Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sisram Medical's EV-to-EBIT falls into.



Sisram Medical EV-to-EBIT Calculation

Sisram Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1685.132/306.602
=5.50

Sisram Medical's current Enterprise Value is HK$1,685 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$307 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sisram Medical  (HKSE:01696) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sisram Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=306.602/2395.49918
=12.80 %

Sisram Medical's Enterprise Value for the quarter that ended in Dec. 2023 was HK$2,395 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sisram Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$307 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sisram Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sisram Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sisram Medical (HKSE:01696) Business Description

Traded in Other Exchanges
N/A
Address
HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Sisram Medical (HKSE:01696) Headlines

No Headlines